Filing Details
- Accession Number:
- 0001645627-17-000061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 12:36:23
- Reporting Period:
- 2017-05-15
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 12:36:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 33,000 shares | Avg. Price: $0.06 | Total Value: $2,016.90 |
| Number of Shares After Transactions: | 20,756,949 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,724,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,725,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,726,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,727,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,728,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,729,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,730,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,731,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 2,000 | $0.06 | 20,733,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 2,000 | $0.06 | 20,735,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 2,000 | $0.06 | 20,737,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,738,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,739,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,740,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,741,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,742,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,743,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,744,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,745,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,746,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,747,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,748,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,749,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,750,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,751,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,752,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,753,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,754,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,755,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 1,000 | $0.06 | 20,756,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
